TheraGenetics Ltd, which produces gene-based tests for establishing the likelihood of a patient responding to a drug or of experiencing side effects, has appointed Heiner Dreismann as chairman.
News - Appointments
Probiodrug AG, a developer of small molecule inhibitors against inflammatory and neurodegenerative diseases, has appointed Hendrik Liebers as its chief financial officer, following a round of new f
The European Medicine Agency’s main scientific committee, the Committee for Medicinal Products for Human Use (CHMP), has elected a new chairman and vice chairman for three-year terms, sta
Sareum Holdings Plc has appointed Giorgio Reggiani as finance director following the retirement of Edward Oliver.
Aisling Burnand, chief executive of the BioIndustry Association (BIA) in Britain, has been named a Member of The Order of the British Empire (MBE) for her services to science.
Probi AB, a Swedish probiotic developer, has appointed Michael Oredsson as chief executive officer, effective in the early autumn of 2007.
The European Medicines Agency (EMEA) has elected a veterinarian as the new chairman of its management board.
Santaris Pharma A/S of Denmark has appointed Flemming Ørnskov as non-executive chairman, effective 24 May 2007.